UBS Group’s Lixte Biotechnology LIXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01K | Sell |
|
|||||
|
2025
Q1 | $10K | Buy |
|
|||||
|
2024
Q4 | $3.97K | Buy |
|
|||||
|
2024
Q3 | $686 | Buy |
|
|||||
|
2024
Q2 | $818 | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $7 | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $594 | Sell |
|
|||||
|
2023
Q1 | $8.87K | Buy |
|
|||||
|
2022
Q4 | $4.83K | Buy |
|
|||||
|
2022
Q3 | $4K | Buy |
|
|||||
|
2022
Q2 | $3K | Sell |
|
|||||
|
2022
Q1 | $9K | Sell |
|
|||||
|
2021
Q4 | $9K | Buy |
|
|||||
|
2021
Q3 | $8K | Buy |
|
|||||
|
2021
Q2 | $6K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $5K | Buy |
|